BeOne Medicines (ONC) Free Cash Flow (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Free Cash Flow data on file, last reported at $158.1 million in Q1 2026.

• On a quarterly basis, Free Cash Flow rose 1092.51% year-over-year to $158.1 million in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 422.21% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 607.38% from the prior year.
• Free Cash Flow for Q1 2026 stood at $158.1 million, down from $508.4 million in the prior quarter.
• Over the last five years, Free Cash Flow for ONC reached as high as $508.4 million in Q4 2025 and fell as low as -$707.3 million in Q3 2022.
• Historically, Free Cash Flow has averaged -$120.8 million across 5 years, with a median of -$54.6 million in 2024.
• Across the five-year window, Free Cash Flow plunged 479.6% in 2022 and surged 1092.51% in 2026, its largest moves.
• Year by year, Free Cash Flow stood at -$439.5 million in 2022, then jumped by 53.17% to -$205.8 million in 2023, then surged by 138.95% to $80.2 million in 2024, then surged by 534.18% to $508.4 million in 2025, then sank by 68.9% to $158.1 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were $158.1 million in Q1 2026, $508.4 million in Q4 2025, and $354.5 million in Q3 2025.